Resources

Results per page

Selected Filters:

ADME-Toxicology Clear Filters

Product Brochures

Percepta flyer

4 Jun 2025

Application Notes

Deepening digitalization in drug discovery at PTC therapeutics

3 Jun 2025

Application Notes

Improving pKa prediction accuracy for PROTACs

3 Jun 2025

Scientific Posters

Quantitative model of P-glycoprotein substrate specificity and its application to predicting unbound brain/plasma partitioning ratio

3 Jun 2025

White Papers

The critical role of evidence-based databases in pharmacogenomics

9 May 2025

Application Notes

MassivEV EV Purification Column PS instruction manual

2 Dec 2024

Application Notes

A new way to study cytokine release syndrome

29 May 2024

Product Brochures

Compare humanized mouse models

4 Apr 2024

Application Notes

In vivo safety and efficacy platform for immunotherapies

4 Apr 2024

Application Notes

Functional characterization of 3D neurospheres assembled using iPSC-derived neurons and astrocytes

13 Mar 2024

Application Notes

The growing importance of mitochondrial toxicity assessment in drug discovery and development

29 Feb 2024

Application Notes

Structural organization and functional analysis of compound response in 3D human iPSC-derived cardiac tri-culture microtissues

31 Jul 2023

White Papers

Antibody drug conjugates

9 Jan 2023

White Papers

CNS drug development

9 Jan 2023

White Papers

Five criteria to use when selecting a CRO for a gene therapy study

9 Jan 2023

White Papers

Human AME (mass balance) studies

9 Jan 2023

White Papers

Selecting the location of a phase I clinical trial site for EU registration

9 Jan 2023

White Papers

Pharmacokinetic studies in patients

9 Jan 2023

White Papers

Plasma protein binding

9 Jan 2023

White Papers

RNAi therapeutics

9 Jan 2023

White Papers

Three lessons to help accelerate pharmaceutical breakthroughs for CNS disorders

9 Jan 2023

White Papers

Regulatory considerations in gene and cellular therapy development

9 Jan 2023

White Papers

Therapeutic oligonucleotide metabolite identification, profiling, and quantitation

9 Jan 2023

Product Brochures

Specification sheet: CyteFinder II HT Imaging System

24 Jul 2022

White Papers

Achieving relevant preclinical characterization of CAR T cell therapies

29 May 2022

Resources

Resources Filter

Search

Selected Filters:

Percepta flyer

Deepening digitalization in drug discovery at PTC therapeutics

Improving pKa prediction accuracy for PROTACs

Quantitative model of P-glycoprotein substrate specificity and its application to predicting unbound brain/plasma partitioning ratio

The critical role of evidence-based databases in pharmacogenomics

MassivEV EV Purification Column PS instruction manual

A new way to study cytokine release syndrome

Compare humanized mouse models

In vivo safety and efficacy platform for immunotherapies

Functional characterization of 3D neurospheres assembled using iPSC-derived neurons and astrocytes

The growing importance of mitochondrial toxicity assessment in drug discovery and development

Structural organization and functional analysis of compound response in 3D human iPSC-derived cardiac tri-culture microtissues

Antibody drug conjugates

CNS drug development

Five criteria to use when selecting a CRO for a gene therapy study

Human AME (mass balance) studies

Selecting the location of a phase I clinical trial site for EU registration

Pharmacokinetic studies in patients

Plasma protein binding

RNAi therapeutics

Three lessons to help accelerate pharmaceutical breakthroughs for CNS disorders

Regulatory considerations in gene and cellular therapy development

Therapeutic oligonucleotide metabolite identification, profiling, and quantitation

Specification sheet: CyteFinder II HT Imaging System

Achieving relevant preclinical characterization of CAR T cell therapies

Resources

Resources FilterResources Filter

Search

Selected Filters:

Percepta flyer

Deepening digitalization in drug discovery at PTC therapeutics

Improving pKa prediction accuracy for PROTACs

Quantitative model of P-glycoprotein substrate specificity and its application to predicting unbound brain/plasma partitioning ratio

The critical role of evidence-based databases in pharmacogenomics

MassivEV EV Purification Column PS instruction manual

A new way to study cytokine release syndrome

Compare humanized mouse models

In vivo safety and efficacy platform for immunotherapies

Functional characterization of 3D neurospheres assembled using iPSC-derived neurons and astrocytes

The growing importance of mitochondrial toxicity assessment in drug discovery and development

Structural organization and functional analysis of compound response in 3D human iPSC-derived cardiac tri-culture microtissues

Antibody drug conjugates

CNS drug development

Five criteria to use when selecting a CRO for a gene therapy study

Human AME (mass balance) studies

Selecting the location of a phase I clinical trial site for EU registration

Pharmacokinetic studies in patients

Plasma protein binding

RNAi therapeutics

Three lessons to help accelerate pharmaceutical breakthroughs for CNS disorders

Regulatory considerations in gene and cellular therapy development

Therapeutic oligonucleotide metabolite identification, profiling, and quantitation

Specification sheet: CyteFinder II HT Imaging System

Achieving relevant preclinical characterization of CAR T cell therapies

Resources Filter